Coldstream Capital Management Inc Dynavax Technologies Corp Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,244 shares of DVAX stock, worth $25,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,244Holding current value
$25,267% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
128MCall Options Held
357KPut Options Held
151K-
Black Rock Inc. New York, NY21.9MShares$247 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$200 Million8.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.7MShares$97.9 Million0.0% of portfolio
-
State Street Corp Boston, MA6.79MShares$76.5 Million0.0% of portfolio
-
Chicago Capital, LLC5.34MShares$60.2 Million1.98% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.42B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...